Medicines for Malaria Venture (MMV)
@mmv.org
A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.
MMV is at #ASTMH25!
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
November 10, 2025 at 5:13 PM
MMV is at #ASTMH25!
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Meet us in the exhibition hall at booth (512) – come for the Swiss chocolate and Italian coffee, stay for chats about our work & partnerships advancing the #malaria elimination agenda.
See all our activities at #TropMed25 this week 👉bit.ly/4hSZTmC
Heading to #ASTMH2025 in Toronto? 🇨🇦
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
November 7, 2025 at 10:40 AM
Heading to #ASTMH2025 in Toronto? 🇨🇦
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV will be on hand in the exhibition hall (booth 512) & throughout the week, sharing research via scientific symposia & poster/oral presentation sessions. Explore MMV & partner activities at the ASTMH Annual Meeting: bit.ly/4hSZTmC
MMV staff are celebrating #MalariaDayInTheAmericas by joining the Brazilian #MedTrop25 Conference in Belém this week!
November 6, 2025 at 8:06 PM
MMV staff are celebrating #MalariaDayInTheAmericas by joining the Brazilian #MedTrop25 Conference in Belém this week!
Symposium: MMV & partners at #ASTMH2025
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
November 3, 2025 at 6:08 PM
Symposium: MMV & partners at #ASTMH2025
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
📅 10 Nov: Evidence to guide the implementation of effective P. vivax radical cure
Lessons from Brazil, Peru, PNG & Indonesia on optimizing radical cure for vivax #malaria relapse prevention
Speakers & topics 👉 bit.ly/3KVqVx7
📣 Applications are open!
The SAHRI Fellowship (2026–2029), funded by @globalhealthedctp3.bsky.social, supports mid-career scientists in sub-Saharan Africa advancing health research & innovation in infectious diseases.
Apply now 👉 bit.ly/4qfTdT6
The SAHRI Fellowship (2026–2029), funded by @globalhealthedctp3.bsky.social, supports mid-career scientists in sub-Saharan Africa advancing health research & innovation in infectious diseases.
Apply now 👉 bit.ly/4qfTdT6
ITM project: SAHRI Fellowship programme
The SAHRI Fellowship programme empowers a new generation of researchers to address critical gaps in health research & innovation in sub-Saharan Africa
bit.ly
October 31, 2025 at 9:57 AM
📣 Applications are open!
The SAHRI Fellowship (2026–2029), funded by @globalhealthedctp3.bsky.social, supports mid-career scientists in sub-Saharan Africa advancing health research & innovation in infectious diseases.
Apply now 👉 bit.ly/4qfTdT6
The SAHRI Fellowship (2026–2029), funded by @globalhealthedctp3.bsky.social, supports mid-career scientists in sub-Saharan Africa advancing health research & innovation in infectious diseases.
Apply now 👉 bit.ly/4qfTdT6
MMV & Chiang Mai University have launched a qualitative study in Thailand on paediatric formulations of primaquine and tafenoquine for P. vivax #malaria relapse prevention, exploring perceptions around their use with G6PD testing.
October 30, 2025 at 11:12 AM
MMV & Chiang Mai University have launched a qualitative study in Thailand on paediatric formulations of primaquine and tafenoquine for P. vivax #malaria relapse prevention, exploring perceptions around their use with G6PD testing.
Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ
October 29, 2025 at 3:37 PM
Malaria can become deadly within hours. Through SEMA ReACT, MMV & partners are studying rectal artesunate use in remote Zambia & DRC to improve severe #malaria care. Join us at #ASTMH2025 (11 Nov) for a symposium sharing interim results & insights 👉 bit.ly/46Z7ADQ
Diversifying the use of #malaria meds through the deployment of MFT can keep us one step ahead of resistance. MMV & partners recently conducted a feasibility study in Kenya demonstrating that an MFT approach is feasible, with adequate resources 👉 bit.ly/3IVeQYh
October 29, 2025 at 1:54 PM
Diversifying the use of #malaria meds through the deployment of MFT can keep us one step ahead of resistance. MMV & partners recently conducted a feasibility study in Kenya demonstrating that an MFT approach is feasible, with adequate resources 👉 bit.ly/3IVeQYh
Are you subscribed to MMV’s monthly newsletter?
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
October 28, 2025 at 8:36 AM
Are you subscribed to MMV’s monthly newsletter?
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
Get the latest news on MMV projects, partnerships & initiatives advancing the global #malaria elimination agenda, as well as info on events, scientific publications & job opportunities within MMV
👉 bit.ly/MMVnewsletter
MMV joins the global health community in mourning the passing of our friend & colleague, Prof. Jean Louis Abdourahim Ndiaye.
As we honour Prof. Ndiaye’s memory, we extend our deepest condolences to his family, close friends & colleagues around the world: shorturl.at/VSzLG
As we honour Prof. Ndiaye’s memory, we extend our deepest condolences to his family, close friends & colleagues around the world: shorturl.at/VSzLG
In memory of Professor Jean Louis Abdourahim Ndiaye | Medicines for Malaria Venture
shorturl.at
October 27, 2025 at 1:45 PM
MMV joins the global health community in mourning the passing of our friend & colleague, Prof. Jean Louis Abdourahim Ndiaye.
As we honour Prof. Ndiaye’s memory, we extend our deepest condolences to his family, close friends & colleagues around the world: shorturl.at/VSzLG
As we honour Prof. Ndiaye’s memory, we extend our deepest condolences to his family, close friends & colleagues around the world: shorturl.at/VSzLG
“Innovation can’t wait; we need to act now,” says MMV CEO Martin Fitchet, in an opinion piece on the urgent need to stop #malaria drug resistance in its tracks. Read it in @devex.com
👉 bit.ly/42UQ8xU
👉 bit.ly/42UQ8xU
October 23, 2025 at 8:00 AM
“Innovation can’t wait; we need to act now,” says MMV CEO Martin Fitchet, in an opinion piece on the urgent need to stop #malaria drug resistance in its tracks. Read it in @devex.com
👉 bit.ly/42UQ8xU
👉 bit.ly/42UQ8xU
A #malaria resurgence would cost lives and crush economies.
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
October 21, 2025 at 10:27 AM
A #malaria resurgence would cost lives and crush economies.
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
A new report warns that without full funding for The Global Fund’s 8th Replenishment, the world risks losing hard-won progress in the fight against malaria.
Read it here 👉 bit.ly/48IJ637
Growing research infrastructure, stronger regulatory frameworks & new opportunities for collaboration are shifting Africa’s clinical trial landscape. 👉 See how harnessing Africa’s untapped clinical trial potential can benefit patients & business: bit.ly/4qema1Z
October 20, 2025 at 1:35 PM
Growing research infrastructure, stronger regulatory frameworks & new opportunities for collaboration are shifting Africa’s clinical trial landscape. 👉 See how harnessing Africa’s untapped clinical trial potential can benefit patients & business: bit.ly/4qema1Z
Reposted by Medicines for Malaria Venture (MMV)
Are you attending #CPHIA2025 in Durban?
Join @mmv.org & Malaria Consortium to explore solutions through #innovation, #surveillance & #partnerships to combat the growing threat of antimalarial drug resistance in Africa.
RSVP: forms.office.com/pages/respon...
#Malaria #HealthSecurity #GlobalHealth
Join @mmv.org & Malaria Consortium to explore solutions through #innovation, #surveillance & #partnerships to combat the growing threat of antimalarial drug resistance in Africa.
RSVP: forms.office.com/pages/respon...
#Malaria #HealthSecurity #GlobalHealth
October 17, 2025 at 9:04 AM
Are you attending #CPHIA2025 in Durban?
Join @mmv.org & Malaria Consortium to explore solutions through #innovation, #surveillance & #partnerships to combat the growing threat of antimalarial drug resistance in Africa.
RSVP: forms.office.com/pages/respon...
#Malaria #HealthSecurity #GlobalHealth
Join @mmv.org & Malaria Consortium to explore solutions through #innovation, #surveillance & #partnerships to combat the growing threat of antimalarial drug resistance in Africa.
RSVP: forms.office.com/pages/respon...
#Malaria #HealthSecurity #GlobalHealth
One country’s victory over #malaria can light the way for others. Suriname's path to elimination was forged by combining community engagement, rapid testing & effective treatment – an approach that can inspire strategies in other countries 👉 bit.ly/4q4jK5R
October 17, 2025 at 10:23 AM
One country’s victory over #malaria can light the way for others. Suriname's path to elimination was forged by combining community engagement, rapid testing & effective treatment – an approach that can inspire strategies in other countries 👉 bit.ly/4q4jK5R
Burundi’s Ministry of Health & @MSF are combining preventive medicines, #vaccines & bed nets to tackle #malaria in the country’s most-affected regions — a powerful three-pronged approach to protect more children.
👉 bit.ly/4nGdZtq
👉 bit.ly/4nGdZtq
A three-pronged approach to combat malaria in Burundi
MSF is supporting 20 health centers where children will receive vaccinations, chemopreventative therapy, and insecticide-treated bed nets.
bit.ly
October 16, 2025 at 10:49 AM
Burundi’s Ministry of Health & @MSF are combining preventive medicines, #vaccines & bed nets to tackle #malaria in the country’s most-affected regions — a powerful three-pronged approach to protect more children.
👉 bit.ly/4nGdZtq
👉 bit.ly/4nGdZtq
Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime.
📅 Nov 12, 7:00am bit.ly/4356K60
📅 Nov 12, 7:00am bit.ly/4356K60
October 15, 2025 at 10:12 AM
Are we focusing on the most critical levers to end #malaria? Join MMV & @gatesfoundation.bsky.social at #ASTMH2025 to explore how breakthrough tools, smart strategies and endemic country leadership can help end malaria in our lifetime.
📅 Nov 12, 7:00am bit.ly/4356K60
📅 Nov 12, 7:00am bit.ly/4356K60
MMV has joined the @who.int Global Clinical Trials Forum – a major step towards more inclusive #malaria research that reflects the people treatments are meant to serve.
Learn more 🔗 bit.ly/47myHc6
Learn more 🔗 bit.ly/47myHc6
MMV joins WHO-led Global Clinical Trials Forum as part of its commitment to equitable and inclusive research | Medicines for Malaria Venture
This new high-profile initiative is set to strengthen the global clinical trial ecosystem through better evidence, coordination, and best practices.
bit.ly
October 14, 2025 at 1:30 PM
MMV has joined the @who.int Global Clinical Trials Forum – a major step towards more inclusive #malaria research that reflects the people treatments are meant to serve.
Learn more 🔗 bit.ly/47myHc6
Learn more 🔗 bit.ly/47myHc6
Ending #malaria could save millions – and generate trillions.
A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA
A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA
New Report: Ending Malaria is a US$4 Trillion Business Opportunity for the U.S. and Africa | Malaria No More
bit.ly
October 13, 2025 at 9:29 AM
Ending #malaria could save millions – and generate trillions.
A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA
A new Malaria No More and Corporate Council on Africa report shows that ending malaria is not just a humanitarian goal, but one of the world’s largest untapped business opportunities: bit.ly/43222pA
#DayOfTheGirl is a reminder that #malaria elimination is only possible if we do what it takes to protect all groups of patients – and build a world where no one’s future can be compromised by a disease that is entirely preventable and treatable. 🌍✨
October 11, 2025 at 10:17 AM
#DayOfTheGirl is a reminder that #malaria elimination is only possible if we do what it takes to protect all groups of patients – and build a world where no one’s future can be compromised by a disease that is entirely preventable and treatable. 🌍✨
Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa.
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
October 7, 2025 at 1:44 PM
Yesterday, MMV and Africa CDC invited partners to a workshop in Accra to exchange insights and brainstorm ways to strengthen regional supply chains for #malaria medicines in Africa.
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Together we’re working to expand access to life-saving treatments where they’re needed most. 🌍💊
Ghana launches Coartem® Baby – the first #malaria medicine for newborns & infants – as momentum continues to build across Africa.
🌍 8 more countries are set to approve soon. bit.ly/4mPN8da
🌍 8 more countries are set to approve soon. bit.ly/4mPN8da
Coartem® Baby launches in Ghana | Medicines for Malaria Venture
Coartem Baby is the first malaria medicine to be approved for young infants
bit.ly
October 7, 2025 at 8:07 AM
Ghana launches Coartem® Baby – the first #malaria medicine for newborns & infants – as momentum continues to build across Africa.
🌍 8 more countries are set to approve soon. bit.ly/4mPN8da
🌍 8 more countries are set to approve soon. bit.ly/4mPN8da
Africa’s first-ever Phase 3 adaptive platform trial of #malaria treatments in early pregnancy has enrolled its first patient in Mali – a landmark moment for the SAFIRE consortium conducting the trial.
Press release 👉 bit.ly/4hbmURr
#SAFIRE4MalariaInPregnancy
Press release 👉 bit.ly/4hbmURr
#SAFIRE4MalariaInPregnancy
First patient enrolled in historic Phase 3 clinical trial to treat malaria in first-trimester pregnancy | Medicines for Malaria Venture
A major milestone in Africa’s first-ever study assessing malaria treatments in early pregnancy.
bit.ly
October 6, 2025 at 12:42 PM
Africa’s first-ever Phase 3 adaptive platform trial of #malaria treatments in early pregnancy has enrolled its first patient in Mali – a landmark moment for the SAFIRE consortium conducting the trial.
Press release 👉 bit.ly/4hbmURr
#SAFIRE4MalariaInPregnancy
Press release 👉 bit.ly/4hbmURr
#SAFIRE4MalariaInPregnancy
Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity.
Together, we can end #malaria – will you join us?
Together, we can end #malaria – will you join us?
September 30, 2025 at 9:39 AM
Meet the organization built on the values it takes to achieve a malaria-free future – collaboration, innovation, openness and equity.
Together, we can end #malaria – will you join us?
Together, we can end #malaria – will you join us?